Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
Birgit S. Geurts, Thomas W. Battaglia, J. Maxime van Berge Henegouwen, Laurien J. Zeverijn, Gijs F. de Wit, Louisa R. Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Paul Roepman, Wendy W.J. de Leng, Anne M.L. Jansen, Frans L. Opdam, Maja J.A. de Jonge, Geert A. Cirkel, Mariette Labots, Ann Hoeben, Emile D. Kerver, Adriaan D. Bins, Frans G.L. Erdkamp, Johan M. van RooijenDanny Houtsma, Mathijs P. Hendriks, Jan Willem B. de Groot, Henk M.W. Verheul, Hans Gelderblom, Emile E. Voest*
Research output: Contribution to journal › Article › Academic › peer-review
7Citations
(Scopus)
23Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours'. Together they form a unique fingerprint.